A

Anagenics Ltd
ASX:AN1

Watchlist Manager
Anagenics Ltd
ASX:AN1
Watchlist
Price: 0.006 AUD Market Closed
Market Cap: AU$2.8m

Net Margin

-24.1%
Current
Improving
by 21.6%
vs 3-y average of -45.7%

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
-24.1%
=
Net Income
AU$-1.2m
/
Revenue
AU$5.1m

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
-24.1%
=
Net Income
AU$-1.2m
/
Revenue
AU$5.1m

Peer Comparison

Country Company Market Cap Net
Margin
AU
Anagenics Ltd
ASX:AN1
3m AUD
Loading...
FR
L'Oreal SA
PAR:OR
206.2B EUR
Loading...
UK
Unilever PLC
LSE:ULVR
121B GBP
Loading...
IN
Hindustan Unilever Ltd
NSE:HINDUNILVR
5.6T INR
Loading...
UK
HALEON PLC
LSE:HLN
33.9B GBP
Loading...
US
Estee Lauder Companies Inc
NYSE:EL
41.5B USD
Loading...
DE
Beiersdorf AG
XETRA:BEI
22B EUR
Loading...
JP
Kao Corp
TSE:4452
2.8T JPY
Loading...
IN
Godrej Consumer Products Ltd
NSE:GODREJCP
1.2T INR
Loading...
IN
Dabur India Ltd
NSE:DABUR
895B INR
Loading...
CA
Relevium Technologies Inc
XTSX:RLV
12.2B CAD
Loading...

Market Distribution

In line with most companies in Australia
Percentile
51st
Based on 4 004 companies
51st percentile
-24.1%
Low
-16 177 900% — -544.7%
Typical Range
-544.7% — 3.1%
High
3.1% — 3 174 540%
Distribution Statistics
Australia
Min -16 177 900%
30th Percentile -544.7%
Median -27.7%
70th Percentile 3.1%
Max 3 174 540%

Anagenics Ltd
Glance View

Market Cap
2.8m AUD
Industry
Consumer products

Anagenics Ltd. operates as a biotechnology company, which engages in the development and marketing of therapies and diagnostic tests for inflammatory and fibrotic diseases, cancer, ischemic diseases of the heart, and hair loss. The company is headquartered in Sydney, New South Wales. The company went IPO on 2005-12-09. The principal activities of the Company include the development, distribution and sale of health, beauty and wellness products (Consumer health). The firm through its wholly owned subsidiary Advangen Pty Ltd, develops, manufactures, markets, distributes to retailers, and sells its anti-aging products globally, with its FGF5 inhibitor, hair health and hair growth products. The flagship anti-aging hair care range, marketed as evolis, Advangen Jo-Ju, and Lexilis brands are sold in Australia, Japan, and the United States of America. The Company’s subsidiary is BLC Cosmetics Pty Limited, which is the distributor of premium Australian and international beauty and wellness brands, primarily to salons and spas.

AN1 Intrinsic Value
0.011 AUD
Undervaluation 47%
Intrinsic Value
Price
A
What is Net Margin?
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
How is Net Margin calculated?

Net Margin is calculated by dividing the Net Income by the Revenue.

Net Margin
-24.1%
=
Net Income
AU$-1.2m
/
Revenue
AU$5.1m
What is Anagenics Ltd's current Net Margin?

The current Net Margin for Anagenics Ltd is -24.1%, which is above its 3-year median of -45.7%.

How has Net Margin changed over time?

Over the last 3 years, Anagenics Ltd’s Net Margin has increased from -52.5% to -24.1%. During this period, it reached a low of -82.8% on Dec 31, 2024 and a high of -24.1% on Jul 30, 2025.

Back to Top